Literature DB >> 22298790

Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.

Chetan B Narshi1, Simon A Allard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22298790     DOI： 10.1093/rheumatology/ker451

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

Review 1.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 2.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

Review 3.  A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

Authors:  Andrea Rubbert-Roth; Daniel E Furst; Jan Michael Nebesky; Angela Jin; Erhan Berber
Journal:  Rheumatol Ther       Date:  2018-03-03

Review 4.  Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.

Authors:  Lijun Liu; Shengyun Liu; Wenjuan Guan; Lei Zhang
Journal:  Rheumatol Int       Date:  2016-06-03       Impact factor: 2.631

Review 5.  Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Authors:  Ghassan Elourimi; Michael Soussan; Ursula Warzocha; Hélène Bugaud; Robin Dhôte; Sébastien Abad
Journal:  Rheumatol Int       Date:  2017-09-30       Impact factor: 2.631

6.  Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review.

Authors:  Rebecca Stael; Vanessa Smith; Ruth Wittoek; David Creytens; Herman Mielants
Journal:  Clin Rheumatol       Date:  2014-05-16       Impact factor: 2.980

Review 7.  The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Authors:  Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

Review 8.  Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.